| __timestamp | Ascendis Pharma A/S | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 6274000 | 34916000 |
| Thursday, January 1, 2015 | 9415000 | 36949000 |
| Friday, January 1, 2016 | 11504000 | 45240000 |
| Sunday, January 1, 2017 | 13482000 | 62416000 |
| Monday, January 1, 2018 | 25057000 | 81289000 |
| Tuesday, January 1, 2019 | 48473000 | 100359000 |
| Wednesday, January 1, 2020 | 76669000 | 105326000 |
| Friday, January 1, 2021 | 160180000 | 122356000 |
| Saturday, January 1, 2022 | 221227000 | 152848000 |
| Sunday, January 1, 2023 | 264410000 | 184259000 |
| Monday, January 1, 2024 | 284545000 |
Unleashing insights
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for sustainable growth. Ascendis Pharma A/S and Corcept Therapeutics Incorporated, two prominent players, have shown distinct trajectories in their SG&A spending from 2014 to 2023. Ascendis Pharma's SG&A expenses have skyrocketed by over 4,100% during this period, reflecting their aggressive expansion and investment in new therapies. In contrast, Corcept Therapeutics has seen a more moderate increase of approximately 430%, indicating a steady growth strategy.
These trends highlight the strategic differences in how these companies allocate resources to support their growth ambitions.
Comparing SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated Trends and Insights
Alnylam Pharmaceuticals, Inc. vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Ascendis Pharma A/S
Cost Management Insights: SG&A Expenses for Intra-Cellular Therapies, Inc. and Ascendis Pharma A/S
Insmed Incorporated and Corcept Therapeutics Incorporated: SG&A Spending Patterns Compared
Annual Revenue Comparison: Ascendis Pharma A/S vs Corcept Therapeutics Incorporated
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Amneal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Ascendis Pharma A/S vs Xencor, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.
Corcept Therapeutics Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Iovance Biotherapeutics, Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs BioCryst Pharmaceuticals, Inc. Trends and Insights